Tom Henry Waddell
ABSTRACT
Obesity is a complex multi-system disease and a growing public health challenge. Recent projections estimate that 71% of the adult population in England will be overweight or obese by 2040. Obesity is associated with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NASH) and a complex set of variables that interact in myriad way. To address this complexity, we use Bayesian-network (BN) analysis to explore the impact of projected increases in obesity prevalence on magnetic resonance imaging (MRI) derived measures of liver steatosis and fibroinflammation in a large UK-based cohort. BNs explicitly model conditional dependencies as a directed acyclic graph, where network variables denote biomarkers and the directed edges connecting such variables the direction of causality. MRI derived measures of liver steatosis (proton density fat fraction [PDFF]) and fibroinflammation (corrected T1 [cT1]) were obtained from 27,002 participants in the UK Biobank. Liver data was combined with additional participant data to construct a BN. The probabilities of being normal weight, overweight, obese, and severely obese in our population were then fixed to 2040 projections. This resulted in an 8% (2160 participants), 5% (1350 participants) and 3% (800 participants) increase in the probability of severe steatosis (PDFF >10%), moderate steatosis (PDFF 5.6-10%) and NASH, respectively. BN analysis models complexity of liver disease and, in this case, illustrates a ‘best case scenario’ of the impact of projected increases in obesity on liver disease. This disproportionately impacts areas of low socio-economic status, and the cost associated with increasing rates of NASH.
- Digital NHS 2019, Health survey for England, viewed 10 December 2022, https://digital.nhs.uk/data-and-information/publications/statistical/health-survey-for-england/2019/main-findingsGoogle Scholar
- Schnurr, T.M., Jakupović, H., Carrasquilla, G.D., Ängquist, L., Grarup, N., Sørensen, T.I., Tjønneland, A., Overvad, K., Pedersen, O., Hansen, T. and Kilpeläinen, T.O., 2020. Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: a case-cohort study. Diabetologia, 63(7), pp.1324-1332.Google Scholar
- Powell-Wiley, T.M., Poirier, P., Burke, L.E., Després, J.P., Gordon-Larsen, P., Lavie, C.J., Lear, S.A., Ndumele, C.E., Neeland, I.J., Sanders, P. and St-Onge, M.P., 2021. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 143(21), pp.e984-e1010.Google Scholar
- Einarson, T.R., Acs, A., Ludwig, C. and Panton, U.H., 2018. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovascular diabetology, 17(1), pp.1-19Google Scholar
- Cancer Intelligence Team, Cancer Research UK. Overweight and obesity prevalence projections for the UK, England, Scotland, Wales, and Northern Ireland, based on data to 2019/20. Published May 2022.Google Scholar
- Public Health England, Health matters: obesity and the food environment, viewed 08 December 2022, https://www.gov.uk/government/publications/health-matters-obesity-and-the-food-environment/health-matters-obesity-and-the-food-environment–2Google Scholar
- McPherson, K., Marsh, T., Brown, M. and Britain, G., 2007. Tackling obesities: future choices: Modelling future trends in obesity and the impact on health. Department of Innovation, Universities and Skills.Google Scholar
- Abeysekera, K.W., Fernandes, G.S., Hammerton, G., Portal, A.J., Gordon, F.H., Heron, J. and Hickman, M., 2020. Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study. The lancet Gastroenterology & hepatology, 5(3), pp.295-305.Google Scholar
- British Liver Trust, 2019. The alarming impact of liver disease in the UK: facts and statistics.Google Scholar
- Morgan, A., Hartmanis, S., Tsochatzis, E., Newsome, P.N., Ryder, S.D., Elliott, R., Floros, L., Hall, R., Higgins, V., Stanley, G. and Cure, S., 2021. Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018. The European Journal of Health Economics, 22(4), pp.505-518.Google Scholar
- Pavlides, M., Banerjee, R., Tunnicliffe, E.M., Kelly, C., Collier, J., Wang, L.M., Fleming, K.A., Cobbold, J.F., Robson, M.D., Neubauer, S. and Barnes, E., 2017. Multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease severity. Liver International, 37(7), pp.1065-1073.Google ScholarCross Ref
- Banerjee, R., Pavlides, M., Tunnicliffe, E.M., Piechnik, S.K., Sarania, N., Philips, R., Collier, J.D., Booth, J.C., Schneider, J.E., Wang, L.M. and Delaney, D.W., 2014. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. Journal of hepatology, 60(1), pp.69-77.Google ScholarCross Ref
- Eddowes, P.J., McDonald, N., Davies, N., Semple, S.I., Kendall, T.J., Hodson, J., Newsome, P.N., Flintham, R.B., Wesolowski, R., Blake, L. and Duarte, R.V., 2018. Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease. Alimentary pharmacology & therapeutics, 47(5), pp.631-644.Google Scholar
- G., Pavlides, M., Sanyal, A.J., Noureddin, M., Banerjee, R. and Dennis, A., 2021. Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis. Clinical Gastroenterology and Hepatology.Google Scholar
- Waddell, T., Bagur, A., Cunha, D., Thomaides‐Brears, H., Banerjee, R., Cuthbertson, D.J., Brown, E., Cusi, K., Després, J.P. and Brady, M., 2022. Greater ectopic fat deposition and liver fibroinflammation, and lower skeletal muscle mass in people with type 2 diabetes. Obesity.Google Scholar
- Li, Y., Chen, X., Shen, Z., Wang, Y., Hu, J., Zhang, Y., Xu, J. and Ding, X., 2020. Prediction models for acute kidney injury in patients with gastrointestinal cancers: a real-world study based on Bayesian networks. Renal failure, 42(1), pp.869-876.Google Scholar
- Tsamardinos, I., Brown, L.E. and Aliferis, C.F., 2006. The max-min hill-climbing Bayesian network structure learning algorithm. Machine learning, 65(1), pp.31-78.Google Scholar
- Mayor, S., 2017. Socioeconomic disadvantage is linked to obesity across generations, UK study finds. BMJ 2017;356:j163.Google Scholar
- Petrie, J.R., Guzik, T.J. and Touyz, R.M., 2018. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Canadian Journal of Cardiology, 34(5), pp.575-584.Google Scholar
Index Terms
- The impact of projected increases in obesity prevalence on incident liver disease in the UK: Insights from Bayesian-network modelling
Recommendations
Quantification of liver fat
Fat accumulation in the liver causes metabolic diseases such as obesity, hypertension, diabetes or dyslipidemia by affecting insulin resistance, and increasing the risk of cardiac complications and cardiovascular disease mortality. Fatty liver diseases ...
Liver fibrosis emulation: Impact of the vascular fibrotic alterations on hemodynamics
AbstractThe liver circulatory system comprises two blood supply vascular trees (the hepatic artery and portal venous networks), microcirculation through the hepatic capillaries (the sinusoids), and a blood drainage vascular tree (the hepatic vein network)...
Graphical abstractDisplay Omitted
Highlights- A novel liver fibrosis model emulating vascular alterations it causes is proposed.
- Pulsatile blood flow and pressure, and elastic vessels are considered in the model.
- Altered sinusoids by fibrous tissue (such as stiffened or ...
Diagnosis of liver disease by using CMAC neural network approach
Liver performs several numbers of metabolic functions that are essential to human life. These functions make the liver one of the most important organs in the human body. There are diseases that occur in the liver in short time (acute) and long time (...
Comments